Two new cancer cases have prompted Kyowa Kirin to shutter all clinical studies of its investigational anti-OX40 monoclonal antibody designed to treat inflammatory diseases. The discontinuation will ...

Arcadia, Castlight Health, Covista, Mission Mobile Medical, Telemedicine.com, TruBridge and Walgreens have come together in an alliance to help state and local markets execute the spending of $50 ...

Without a doubt, one of the hottest new startup accelerators in tech right now is Andreessen Horowitz’s Speedrun program. Launched in 2023, the accelerator has an acceptance rate of less than 1%. In a ...

Microsoft has announced the Store CLI, a command-line interface for managing and installing Windows apps from the Microsoft Store. It's similar to WinGet, except the Store CLI only works for apps that ...

The execution of the program without a warning is what Microsoft considers to be the remote code execution flaw. Windows 11 command prompt launched without a warning Source: BTtea This could ...

TURKU, Finland, Feb. 10, 2026 /PRNewswire/ -- Vaadin, the leading provider of Java web application frameworks, today announced the general availability of Swing Modernization Toolkit, a solution that ...

Tech expert ThioJoe explores 11 command line tools that can boost your workflow efficiency. Iran sends first significant message of de-escalation, but with a major caveat NATO scrambles military jets ...

You know the number. Maybe it’s a sub-4 marathon, a sub-7 mile, or another barrier you’re determined to break. No matter what it is for you, there’s no greater feeling than finally achieving a speed ...

ThioJoe explores 11 command line tools that can boost your workflow efficiency. Trump suffers fact check over Rep. Omar Actor James Ransone, who starred in 'The Wire,' dies from an apparent suicide at ...

MINNEAPOLIS (AP) — Half or more of the roughly $18 billion in federal funds that supported 14 Minnesota-run programs since 2018 may have been stolen, a federal prosecutor said Thursday, describing the ...

Daiichi Sankyo and Merck & Co.’s phase 3 program for their investigational antibody-drug conjugate has been hit with a hold after an unexpected number of deaths were reported in the global trial. “Due ...